Cargando…
Recommendations for the management of tyrosinaemia type 1
The management of tyrosinaemia type 1 (HT1, fumarylacetoacetase deficiency) has been revolutionised by the introduction of nitisinone but dietary treatment remains essential and the management is not easy. In this review detailed recommendations for the management are made based on expert opinion, p...
Autores principales: | de Laet, Corinne, Dionisi-Vici, Carlo, Leonard, James V, McKiernan, Patrick, Mitchell, Grant, Monti, Lidia, de Baulny, Hélène Ogier, Pintos-Morell, Guillem, Spiekerkötter, Ute |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3558375/ https://www.ncbi.nlm.nih.gov/pubmed/23311542 http://dx.doi.org/10.1186/1750-1172-8-8 |
Ejemplares similares
-
Cross-sectional study of 168 patients with hepatorenal tyrosinaemia and implications for clinical practice
por: Mayorandan, Sebene, et al.
Publicado: (2014) -
Natural Protein Tolerance and Metabolic Control in Patients with Hereditary Tyrosinaemia Type 1
por: Yilmaz, Ozlem, et al.
Publicado: (2020) -
Determinants of tyrosinaemia during nitisinone therapy in alkaptonuria
por: Ranganath, L. R., et al.
Publicado: (2022) -
UK Dietary Practices for Tyrosinaemias: Time for Change
por: Daly, Anne, et al.
Publicado: (2022) -
Diazoxide-responsive hyperinsulinaemic hypoglycaemia in tyrosinaemia type 1
por: Sotiridou, Ellada, et al.
Publicado: (2021)